New Tulsa Cancer Institute Offers Accuray's Latest Cancer Fighting Technology SUNNYVALE, Calif. , June 25, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that the Tulsa Cancer Institute is the first U.S. center to treat a patient with Accuray's TomoHDA™ System , the
Lancaster General Health Unveils Leading Robotic Radiosurgery System SUNNYVALE, Calif. , June 13, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that Lancaster General Health in Pennsylvania is the first U.S. center to treat a patient with the CyberKnife® M6™ System , the
Advanced Radiation Treatment Now Available to Cancer Patients in France SUNNYVALE, Calif. , June 5, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today the first patient has been treated with its new TomoHDA™ System at Centre Oscar Lambret in Lille, France .
Receives Omega's prestigious NorthFace ScoreBoard AwardSM for exceeding customer expectations SUNNYVALE, Calif. , May 29, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today it has received the NorthFace ScoreBoard Award SM from Omega Management Group Corp .
SUNNYVALE, Calif. , May 22, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that its management is scheduled to present at the 2013 Jefferies Global Healthcare Conference in New York on Thursday, June 6, 2013 at 1:30 p.m. EDT / 10:30 a.m. PDT .
Updated ASTRO Model Policy Endorses Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer SUNNYVALE, Calif. , May 21, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today the publication of study results involving hundreds of prostate cancer patients treated with the
New Order Activity Improves - First Installations of New Models - Guidance Updated SUNNYVALE, Calif. , May 7, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today announced financial results for the third quarter of fiscal 2013 that ended March 31, 2013 .
SUNNYVALE, Calif. , April 18, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), a radiation oncology company, today announced that it will report results for its third quarter of fiscal 2013, ended March 31, 2013 on Tuesday, May 7, 2013 after the market closes.
SUNNYVALE, Calif. , April 18, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today clarification on two voluntary recalls that the company initiated on March 19, 2013 . In keeping with its commitment to patient safety and total quality management, Accuray has voluntarily
Heidelberg University Hospital pioneers use; providing precise and efficient treatments SUNNYVALE, Calif. , April 4, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that Heidelberg University Hospital , Germany , has treated the world's first patients with the new
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
